Terns Pharmaceuticals, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
TERN on Nasdaq
Industry
Pharmaceutical Preparations
Location
1065 East Hillsdale Blvd., Suite 100, Foster City, CA

Insiders trading volume in the past year

Terns Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vivo Opportunity, LLC 10%+ Owner $38.7M Apr 1, 2024
Carl L. Gordon Director, 10%+ Owner $7.56M Jul 15, 2024
Orbimed Advisors Llc Director, 10%+ Owner $7.56M Jul 15, 2024
Hongbo Lu Director $5M Jun 11, 2025
LAV Biosciences Fund V, L.P. 10%+ Owner $2M Nov 23, 2022
David Strauss Principal Accounting Officer $520K Feb 1, 2025
Mark J. Vignola Chief Financial Officer $433K -$99K -18.6% Jan 2, 2025
Seokho Bryan Yoon COO and General Counsel $408K May 31, 2024
Emil Kuriakose Chief Medical Officer $404K -$39K -8.8% Oct 1, 2025
Erin Quirk President, Head of R&D $284K Jan 23, 2024
Amy L. Burroughs Chief Executive Officer, Director $182K +$203K Jun 25, 2025
Andrew Gengos Chief Financial Officer $98.2K +$96.4K +5123% Jun 27, 2025
Senthil Sundaram Chief Executive Officer, Director $36.9K May 31, 2023
Melita Sun Jung Chief Business Officer $11.5K +$11.5K Jan 30, 2025
Jill M. Quigley Director $0 -$528K -100% Nov 4, 2025
Kerry Strong Russell Chief Medical Officer Jul 1, 2022
Ann Elizabeth Taylor Director Jul 1, 2024
Radhika Tripuraneni Director Jun 11, 2025
Jeffrey B. Kindler Director Jun 11, 2025
David A. Fellows Director Jun 11, 2025
Robert Azelby Director Feb 20, 2025
Heather D. Turner Director Jun 11, 2025

Recent Insider Transactions by Companies or Individuals for Terns Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.